Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF-inhibitor : results from 13 European registries

Linde, L, Ørnbjerg, L M, Georgiadis, S, Rasmussen, S H, Lindström, U, Askling, J, Michelsen, B, Di Giuseppe, D, Wallman, J K, Gudbjornsson, B, Love, T J, Nordström, D, Yli-Kerttula, T, Nekvindova, L, Vencovský, J, Iannone, F, Cauli, A, Loft, A G, Glintborg, B, Laas, K, Rotar, Z, Tomšič, M, Macfarlane, G, Möller, B, Van de Sande, M G H, Codreanu, C, Nissen, M J, Birlik, M, Erten, S, Santos, M J, Vieira-Sousa, E, Hetland, M L & Østergaard, M 2024, 'Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF-inhibitor : results from 13 European registries', Rheumatology, vol. 63, no. 3, pp. 751–764. https://doi.org/10.1093/rheumatology/kead284